Ironshore Therapeutics Overview
- Year Founded
-
2008
- Status
-
Acquired/Merged
- Employees
-
10
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$646M
Ironshore Therapeutics General Information
Description
Developer of proprietary drugs designed to develop and commercialize first-in-class treatment options to improve the lives of patients and caregivers. The company's drug delivery system offers oral controlled-release technology for evening dosing of medication with delayed and extended-release characteristics to provide for next-day therapeutic activity beginning in the early morning and lasting throughout the day, enabling ADHD patients and their families to address unmet medical needs to treat ADHD conditions during the morning routine.
Contact Information
Website
www.ironshorepharma.com(Operating Subsidiary)
Corporate Office
- 430 Davis Drive
- Suite 250
- Morrisville, NC 27560
- United States
Corporate Office
- 430 Davis Drive
- Suite 250
- Morrisville, NC 27560
- United States
Ironshore Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Merger/Acquisition | 04-Sep-2024 | $646M | Completed | Generating Revenue | ||
| 6. Debt - General | 01-Jan-2022 | Completed | Generating Revenue | |||
| 5. Debt - General | 24-Jan-2017 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series A) | 25-Jun-2015 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series A) | 16-Oct-2014 | Completed | Generating Revenue | |||
| 2. Later Stage VC (Series A) | 15-Aug-2013 | $6.7M | $7.13M | Completed | Generating Revenue | |
| 1. Angel (individual) | 28-Oct-2008 | $431K | $431K | Completed | Startup |
Ironshore Therapeutics Comparisons
Industry
Financing
Details
Ironshore Therapeutics Competitors (30)
One of Ironshore Therapeutics’s 30 competitors is Cingulate, a Formerly VC-backed company based in Kansas City, KS.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Cingulate | Formerly VC-backed | Kansas City, KS | ||||
| AnTolRx | Venture Capital-Backed | Cambridge, MA | ||||
| Kinoxis Therapeutics | Venture Capital-Backed | Melbourne, Australia | ||||
| Ability Pharma | Private Equity-Backed | Barcelona, Spain | ||||
| Ripple Therapeutics | Venture Capital-Backed | Toronto, Canada |
Ironshore Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Ironshore Therapeutics Patents
Ironshore Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2023033571-A | Methylphenidate compositions for treating attention deficit hyperactivity disorder | Inactive | 25-Jan-2019 | ||
| EP-3914248-A1 | Methylphenidate compositions for treatment of attention deficit hyperactivity disorder | Pending | 25-Jan-2019 | ||
| EP-3914248-A4 | Methylphenidate compositions for treatment of attention deficit hyperactivity disorder | Pending | 25-Jan-2019 | ||
| CA-2830788-A1 | Methods and compositions for treatment of attention deficit disorder | Active | 23-Mar-2011 | ||
| JP-2016117767-A | Methods and compositions for treatment of attention deficit disorder | Inactive | 23-Mar-2011 | A61K9/0053 |
Ironshore Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Ironshore Therapeutics Former Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Citibank Group | Corporation | Minority | ||
| Eastern Capital (Pakistan) | Venture Capital | Minority | ||
| Highland's Clinical Development group | Corporation | Minority |
Ironshore Therapeutics FAQs
-
When was Ironshore Therapeutics founded?
Ironshore Therapeutics was founded in 2008.
-
Where is Ironshore Therapeutics headquartered?
Ironshore Therapeutics is headquartered in Morrisville, NC.
-
What is the size of Ironshore Therapeutics?
Ironshore Therapeutics has 10 total employees.
-
What industry is Ironshore Therapeutics in?
Ironshore Therapeutics’s primary industry is Drug Delivery.
-
Is Ironshore Therapeutics a private or public company?
Ironshore Therapeutics is a Private company.
-
What is the current valuation of Ironshore Therapeutics?
The current valuation of Ironshore Therapeutics is .
-
What is Ironshore Therapeutics’s current revenue?
The current revenue for Ironshore Therapeutics is .
-
How much funding has Ironshore Therapeutics raised over time?
Ironshore Therapeutics has raised $345M.
-
Who are Ironshore Therapeutics’s investors?
Citibank Group, Eastern Capital (Pakistan), and Highland's Clinical Development group have invested in Ironshore Therapeutics.
-
Who are Ironshore Therapeutics’s competitors?
Cingulate, AnTolRx, Kinoxis Therapeutics, Ability Pharma, and Ripple Therapeutics are some of the 30 competitors of Ironshore Therapeutics.
-
When was Ironshore Therapeutics acquired?
Ironshore Therapeutics was acquired on 04-Sep-2024.
-
Who acquired Ironshore Therapeutics?
Ironshore Therapeutics was acquired by Collegium Pharmaceutical.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
